MINERVA GROUP(00397)
Search documents
嬴集团(00397) - (1) 授出购回股份及发行新股份的一般授权;(2) 重选退任董事;及 (3...
2025-04-25 09:35
此乃要件 請即處理 閣下如 對本通函任何方面或應採取的行動 有任何疑問,應諮詢 閣下的股票經紀或其他註冊證 券交易商、銀行經理、律師、專業會計師或其他專業顧問。 閣下如 已 將 名 下 的 嬴 集 團 控 股 有 限 公 司(「本公司」)股 份 全 部 出售或轉讓,應立即將本通函連同 隨附的代表委任表格送交買主或承讓人,或經手買賣或轉讓的銀行、股票經紀或其他代理商, 以便轉交買主或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示概不就因本通函全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 Minerva Group Holding Limited 嬴集團控股有限公司* (於百慕達註冊成立之有限公司) (股份代號:397) (1)授出購回股份及發行新股份的一般授權; (2)重選退任董事; 及 (3)股東週年大會通告 本 公 司 謹 訂 於 二 零 二 五 年 六 月 十 三 日(星 期 五)上 午 十 時 正 假 座 香 港 中 環 德 輔 道 中19號環球大廈 21樓2102室 舉 行 股 東 週 年 ...
嬴集团(00397) - 2024 - 年度财报
2025-04-25 09:31
Financial Performance - The company recorded a revenue of approximately HKD 68.9 million for the fiscal year ending December 31, 2024, a decrease from HKD 74.1 million in 2023, primarily due to reduced interest income from lending operations [14]. - The net loss attributable to the company's owners was approximately HKD 143.9 million, significantly higher than the HKD 104.1 million loss in 2023, largely due to fair value losses on financial assets amounting to HKD 87.0 million [15]. - The overall gross profit decreased to approximately HKD 64.3 million from HKD 69.7 million in the previous year, despite enhanced operational cost control measures [14]. - The lending business generated approximately HKD 52.4 million in revenue, a slight decrease from HKD 55.1 million in the previous year [14]. - The financial services segment's revenue decreased to approximately HKD 15.5 million from HKD 18.0 million in 2023 [14]. - Interest income from clients, including margin clients and cash clients, was approximately HKD 12.4 million this year, down from HKD 16.5 million in 2023 [19]. - The group’s lending segment generated revenue of approximately HKD 52.4 million, accounting for about 76.1% of total revenue, with an operating loss of approximately HKD 47.3 million, a decrease of about 426.2% compared to the previous year [31]. - The impairment loss on loans and interest receivable was approximately HKD 74.3 million, an increase from HKD 24.1 million in the previous year, primarily due to increased uncertainty in the recoverability of overdue loans [33]. Economic Environment - The company faced significant challenges, including a 20.1% decline in the Hang Seng Composite Index for healthcare, impacting its equity investments [10]. - The company anticipates a gradual stabilization of the Hong Kong and global economy by 2025, while remaining vigilant about ongoing credit default risks [11]. - The Hang Seng Index recorded a 17.7% increase this year, while the Hang Seng Composite Industry Index showed significant differences, with the information technology sector growing by 43.3% and the healthcare sector declining by 20.1% [16]. - The estimated market value of the Hong Kong capital market is $5.01 trillion, significantly impacted by the US-China trade war and geopolitical instability, with office values plummeting by 40% since 2018 [61]. - The GDP growth forecast for Hong Kong has been revised down from 3.2% to 2.5% for 2024, indicating a fragile future amid a severe economic climate [61]. Risk Management - The company is adopting a more cautious approach to manage rising credit risks and interest rate pressures, preparing for additional impairments to safeguard operations [9]. - The group has implemented strict credit policies and controls to mitigate credit risks, with a focus on maintaining loan quality amid economic uncertainty [23]. - The credit committee is responsible for evaluating and approving loans within predetermined credit limits and regularly monitors the credit quality of the loan portfolio [24]. - The group actively monitors its loan portfolio and conducts targeted negotiations and due diligence to minimize losses from expected credit losses [34]. - The group will conduct regular reviews of its internal control systems, including credit policies and operational manuals, to ensure compliance with applicable regulations [28]. - The company has established a robust risk management and internal control system, which is reviewed annually to ensure effectiveness in safeguarding shareholder interests and assets [188]. - An internal control consultant was appointed to assist in identifying and assessing risks and to conduct independent audits of the internal control system [191]. - The company has established an enterprise risk management framework aligned with the internationally recognized COSO framework [193]. Investment Strategy - The group plans to restructure its securities capital market business to identify and assess profitable transactions, expecting this segment to continue growing as a significant source of revenue [20]. - The group aims to explore potential lending opportunities, including project financing, depending on market conditions and risk-return assessments [21]. - The company has shifted its investment strategy to focus on sectors with better performance, including margin financing and lending activities [46]. - The company is exploring investment opportunities in fintech, healthcare, and biotechnology sectors, viewing current market conditions as potential investment opportunities rather than setbacks [48]. - The group maintains a portfolio of Hong Kong listed stocks to manage and diversify investment risks, regularly reviewing investment strategies based on market conditions [48]. Shareholder and Corporate Governance - The company has approximately HKD 1,061,166,000 available for distribution to shareholders as of December 31, 2024 [107]. - The board does not recommend a dividend for the current year, consistent with the previous year where no dividend was paid [89]. - The company has undergone changes in its board of directors, with several new independent non-executive directors appointed in recent years [81][82]. - The board of directors consists of five members, including two executive directors and three independent non-executive directors [141]. - The board has established committees to delegate certain management and administrative functions, ensuring effective corporate governance [153]. - The company has adopted all code provisions of the Corporate Governance Code as set out in the Listing Rules [138]. - The company has complied with all necessary regulations regarding board composition, including the appointment of independent non-executive directors [178]. Employee and Social Responsibility - The group employs 27 staff members and provides regular training to enhance employee capabilities [70]. - The company has implemented various policies to promote energy and paper conservation among employees, aiming to reduce resource consumption and costs [97]. - The group reported a total charitable donation of HKD 483,000 for the year, a significant increase from HKD 43,000 in the previous year [91]. - The gender ratio of employees as of December 31, 2024, is approximately 58% male and 42% female, indicating a commitment to gender equality in hiring and employee development [182]. Audit and Compliance - The audit committee held two meetings during the year to review the audited consolidated financial statements for the year ending December 31, 2023, and the unaudited consolidated financial information for the six months ending June 30, 2024 [185]. - The total fees paid or payable to the auditor for audit services amounted to HKD 940,000, with no fees for non-audit services [186]. - The audit committee recommended the approval of the audited consolidated financial statements and discussed the effectiveness of the risk management and internal control systems [185]. - The company emphasizes transparency in internal control and compliance matters, with measures in place for handling and disclosing inside information [192].
嬴集团(00397) - 翌日披露报表
2025-04-24 12:31
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: Minerva Group Holding Limited 呈交日期: 2025年4月24日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00397 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 事件 | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | 每股發行/出售價 (註4) | ...
嬴集团(00397) - 翌日披露报表
2025-04-23 11:03
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: Minerva Group Holding Limited 呈交日期: 2025年4月23日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00397 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有 ...
嬴集团(00397) - 翌日披露报表
2025-04-22 11:10
翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: Minerva Group Holding Limited 呈交日期: 2025年4月22日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00397 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現 ...
嬴集团(00397) - 翌日披露报表
2025-04-17 11:17
FF305 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00397 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現有已發 行股份(不包括庫存股 份)數目百分比 (註3) | | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年4月16日 | 2,505,282,734 | | | 0 | | 2,505,282,734 | | 1). 其他 (請註明) | | | 0 | 0 % | | | | | 見 B 部分 | | | | | | | | | 變動日期 | 2025年4月17日 | | | | ...
嬴集团(00397) - 翌日披露报表
2025-04-16 11:05
翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: Minerva Group Holding Limited 呈交日期: 2025年4月16日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00397 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現 ...
嬴集团(00397) - 翌日披露报表
2025-04-15 11:00
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: Minerva Group Holding Limited 呈交日期: 2025年4月15日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00397 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有 ...
嬴集团(00397) - 2024 - 年度业绩
2025-03-28 12:33
Financial Performance - The group recorded revenue of approximately HKD 68.9 million for the year ended December 31, 2024, a decrease of 7.5% from HKD 74.1 million in 2023[3] - The loss attributable to the owners of the company was approximately HKD 143.9 million, compared to a loss of HKD 104.1 million in 2023, representing an increase of 38.4%[3] - The basic loss per share increased to HKD 5.74 from HKD 3.82 in 2023, reflecting a worsening of financial performance[5] - The group reported a total loss before tax of HKD 143,920,000 for the year, compared to a loss of HKD 108,702,000 in the previous year[25] - The company reported a pre-tax loss of HKD 107,122,000, primarily due to significant losses in the investment category amounting to HKD 124,748,000[27] - The overall gross profit decreased to approximately HKD 64.3 million for the year, down from HKD 69.7 million in 2023, despite enhanced operational cost control measures[60] Cash and Assets - The group's cash and bank balances were approximately HKD 143.3 million, down from HKD 188.0 million in 2023, a decrease of 23.7%[3] - Total assets less current liabilities decreased to HKD 1,131.2 million from HKD 1,276.6 million in 2023, a decline of 11.4%[7] - The group's non-current assets decreased to HKD 164.96 million from HKD 195.03 million in 2023, a reduction of 15.4%[6] - Total assets decreased from HKD 1,325,798,000 in 2023 to HKD 1,171,828,000 in 2024, reflecting a decline of approximately 11.6%[29] - The company’s total equity decreased from HKD 1,276,639,000 in 2023 to HKD 1,130,877,000 in 2024, reflecting a decline of approximately 11.4%[29] Revenue Segments - The financial services segment generated revenue of HKD 15,544,000, while the lending segment contributed HKD 52,396,000[25] - Total revenue from external customers reached HKD 74,072,000, with contributions of HKD 17,976,000 from financial services, HKD 55,076,000 from lending, and HKD 1,020,000 from investments[27] - Interest income from lending decreased to HKD 52,396,000 in 2024 from HKD 55,076,000 in 2023, representing a decline of 4.1%[22] - Securities brokerage commission income increased to HKD 944,000 in 2024 from HKD 732,000 in 2023, a growth of 29.0%[23] - Placement commission income rose significantly to HKD 1,439,000 in 2024 from HKD 300,000 in 2023, marking an increase of 379.7%[23] - Corporate finance advisory service income doubled to HKD 790,000 in 2024 from HKD 395,000 in 2023, reflecting a 100.0% increase[23] Liabilities and Impairments - The total liabilities decreased from HKD 49,159,000 in 2023 to HKD 40,951,000 in 2024, a reduction of approximately 16.5%[29] - The company experienced a significant increase in impairment losses on loans and interest, rising from HKD 24,114,000 in 2023 to HKD 74,326,000 in 2024[33] - The group recognized a loan and interest impairment loss of approximately HKD 74.3 million for the year, compared to HKD 24.1 million in 2023, primarily due to increased uncertainty regarding the recoverability of certain overdue loans[76] - The provision for impairment of receivables increased significantly, with HKD 74,326 thousand recognized in 2024 compared to HKD 24,114 thousand in 2023[40] Dividends and Shareholder Returns - The group did not recommend a final dividend for the year ended December 31, 2024, compared to no dividend in 2023[2] - No dividends were declared or proposed for the year ending December 31, 2024, consistent with the previous year[37] Legal Matters - Classictime Investments Limited is involved in a legal case where the plaintiffs claim damages due to alleged misconduct by the defendants, including improper share distribution and breach of fiduciary duties[51] - The plaintiffs are seeking a court order to cancel shares allocated to Classictime, along with damages, interest, and further relief[51] - The legal proceedings related to the claims are still in preliminary stages, making it difficult to quantify any potential financial impact on the group[58] Market Conditions and Future Outlook - The healthcare sector experienced a significant decline of 20.1% in the Hang Seng Composite Index, impacting the company's financial performance negatively[62] - The company anticipates ongoing challenges, including uncertain monetary policies and inflation pressures in Hong Kong, as well as a tightening credit environment due to rising non-performing loans[63] - The group is exploring investment opportunities in financial technology, healthcare, and biotechnology sectors, viewing the current economic situation as an investment opportunity rather than a setback[87] - The Hong Kong capital market is under significant pressure, with a projected GDP growth decline from 3.2% to 2.5% in 2024 due to various global economic challenges[95] Internal Controls and Governance - The group maintains strict internal controls and credit policies to mitigate credit risk, especially in light of increasing economic uncertainty[67] - The group regularly reviews its internal control systems, including credit policies and operational manuals, to ensure compliance with applicable regulations[72] - The company maintained good corporate governance standards and complied with the corporate governance code throughout the year[106] - The audit committee reviewed the consolidated financial statements and found no objections regarding the accounting principles and practices adopted by the group[108]
嬴集团(00397) - 有关截至二零二四年十二月三十一日止年度盈利警告公告的补充公告
2025-03-25 09:24
Minerva Group Holding Limited 嬴集團控股有限公司* (於百慕達註冊成立之有限公司) (股份代號:397) 有關截至二零二四年十二月三十一日止年度 盈利警告公告的補充公告 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示 概 不 就 因 本 公 告 全 部 或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 本 公 告 乃 由 嬴 集 團 控 股 有 限 公 司(「本公司」,連 同 其 附 屬 公 司 統 稱「本集團」)根 據香港聯合交易所有限公司證券上市規則第13.09(2)(a)條及香港法例第571章 證 券及期貨條例第XIVA部內幕消息條文而作出。 茲提述本集團日期為二零二五年一月十七日的截至二零二四年十二月三十一日 止 年 度 的 盈 利 警 告 公 告(「盈利警告」)。除 本 公 告 另 有 界 定 者 外,本 公 告 所 用 詞 彙 與盈利警告所界定者具有相同涵義。 本 公 司 董 事 會(「董事會」)謹 此 知 會 本 公 司 股 東(「股 ...